PUBLICATIONS DATABASE
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
International Journal of Chronic Obstructive Pulmonary Disease
17 August 2017
Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres, David Price
Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes
Journal of Allergy and Clinical Immunology: In Practice
1 August 2017
David Price, Miguel Román Rodríguez, R. Brett McQueen, Sinthia Bosnic-Anticevich, Victoria Carter, Kevin Gruffyd-Jones, John Haughney, Svein Høegh Henrichsen, Catherine Hutton, Antonio Infantino, Federico Lavorini, Lisa M Law, Karin Lisspers, Alberto Papi, Dermot Ryan, Björn Ställberg, Thys van der Molen, Henry Chrystyn
Blood eosinophil count and exacerbation risk in patients with COPD
European Respiratory Journal
20 July 2017
Marjan Kerkhof, Samatha Sonnappa, Dirkje Postma, Guy Brusselle, Alvar Agustí, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian Pavord, Emilio Pizzichini, Todor Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V Hillyer, David Price
Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol: a real-life effectiveness and cost impact evaluation
Respiratory Medicine
24 June 2017
Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffyd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d’Alcontres, David Price
Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database
Pragmatic and Observational Research
18 May 2017
David Price, Eran Gefen, Gokul Gopalan, Cristiana Miglio, Rosie McDonald, Vicky Thomas, Simon Wan Yau Ming
Ipratropium/Salbutamol comparator versus originator for chronic obstructive pulmonary disease exacerbations: US observational cohort study using the Clinformatics™ health claims database
Pulmonary Therapy
24 April 2017
Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming, David Price
Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study
Clinical Epidemiology
17 April 2017
Jens Dollerup, Jørgen Vestbo, Tarita Murray-Thomas, Alan Kaplan, Richard J Martin, Emilio Pizzichini, Marcia M M Pizzichini, Annie Burden, Jessica Martin, David Price
Cohort analysis of exacerbation rates in adolescent and adult patients initiating inhaled corticosteroids for asthma: different dose-response profile by particle size
Pulmonary Therapy
12 April 2017
Dirkje Postma, Alan Kaplan, Joan B. Soriano, Jonathon Grigg, Theresa W Guilbert, Willem M.C. van Aalderen, Nicolas Roche, Annie Burden, Elizabeth V Hillyer, Elliot Israel, David Price
A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma
Journal of Allergy and Clinical Immunology: In Practice
25 March 2017
Omar S. Usmani, Anu Kemppinen, Elizabeth Gardener, Vicky Thomas, Priyanka Raju Konduru, Christina Callan, Andrew McLoughlin, Vanessa Woodhead, Adam Brady, Elizabeth F Juniper, Peter J Barnes, David Price
An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
Pragmatic and Observational Research
22 March 2017
Annie Burden, Nicolas Roche, Cristiana Miglio, Elizabeth V Hillyer, Dirkje Postma, R. Brett McQueen, Ron M.C. Herings, Jetty A. Overbeek, Javaria Mona Khalid, Daniela van Eickels, Joan B. Soriano, David Price
Real-life outcomes for patients with asthma prescribed spacers for use with either extrafine- or fine-particle inhaled corticosteroids
Journal of Allergy and Clinical Immunology: In Practice
18 January 2017
Theresa W Guilbert, Gene Colice, Jonathan Grigg, Willem M.C. van Aalderen, Richard J Martin, Elliot Israel, Dirkje Postma, Nicolas Roche, Wanda Phipatanakul, Elizabeth V Hillyer, Jennifer M. Evans, Myrna B Dolovich, David Price, The Respiratory Effectiveness Group
Identifying risk of future asthma attacks using UK medical record data: a Respiratory Effectiveness Group initiative
Journal of Allergy and Clinical Immunology: In Practice
22 December 2016
John D Blakey, David Price, Emilio Pizzichini, Todor Popov, Borislav D Dimitrov, Dirkje Postma, Lynn K. Josephs, Alan Kaplan, Alberto Papi, Marjan Kerkhof, Elizabeth V Hillyer, Alison Chisholm, Mike Thomas
Inappropriate asthma therapy — a tale of two countries: a parallel population-based cohort study
NPJ Primary Care Respiratory Medicine
13 October 2016
Manon Belhassen, Anjan Nibber, Eric Van Ganse, Dermot Ryan, Carole Langlois, Francis Appiagyei, Derek Skinner, Laurent Laforest, Joan B Soriano, David Price
Asthma-related outcomes in patients initiating extrafine ciclesonide or fine-particle inhaled corticosteroids
Allergy, Asthma & Immunology Research
11 October 2016
Dirkje Postma, Richard Dekhuijzen, Thys van der Molen, Richard J Martin, Willem M.C. van Aalderen, Nicolas Roche, Theresa W Guilbert, Elliot Israel, Daniela van Eickels, Javaria Mona Khalid, Ron M.C. Herings, Jetty A. Overbeek, Cristiana Miglio, Victoria Thomas, Catherine Hutton, Elizabeth V Hillyer, David Price